Podcast

Pharmacy Focus: Psychedelic Pharmacy - The Future of Ketamine

Industry partnerships will be essential to improving access to ketamine, according to expert Kevin Nicholson.

This month, we spoke with Kevin Nicholson, CEO of Ketamine Wellness Centers and recently-announced CEO of Delic Corp., to discuss the future of ketamine research and why industry partnerships will be crucial to improving access.

Related Videos
Pharmacist and patient in a community pharmacy -- Image credit: Gorodenkoff | stock.adobe.com
X-ray image of human brain with neurons -- Image credit: Who is Danny | stock.adobe.com
Related Content
Precision medicine in neurology -- Image credit: Evon J | stock.adobe.com
April 9th 2025

AAN 2025: Precision Medicine and Pharmacogenomics in Neurological Care

Gillian McGovern, Associate Editor
Updates to Acute Coronary Syndrome Guidelines
April 8th 2025

Updates to Acute Coronary Syndrome Guidelines

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Aislinn Antrim, Managing Editor
Child with a migraine -- Image credit: irena_geo | stock.adobe.com
April 8th 2025

AAN 2025: Fremanezumab Superior to Placebo in Reducing Monthly Migraine Days in Children and Adolescents

Gillian McGovern, Associate Editor
Everything You Need to Know From the American College of Cardiology 2025 Scientific Session
April 1st 2025

Everything You Need to Know From the American College of Cardiology 2025 Scientific Session

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Aislinn Antrim, Managing Editor
Medical - Image credit: BillionPhotos.com | stock.adobe.com
April 4th 2025

FDA Grants Fast Track Designation to Investigational Tau-Targeting Therapy for Alzheimer Disease

Kennedy Ferruggia, Assistant Editor
Depiction of mental illness -- Image credit: tadamichi | stock.adobe.com
April 2nd 2025

How Pharmacies Can Better Support Employees Living With Serious Mental Illness

Michael McGuire, PharmD